Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy Volunteers
Interventions: DRUG: AZD9833|DRUG: Midazolam|DRUG: Omeprazole|DRUG: Dabigatran Etexilate|DRUG: Celecoxib
Sponsor: AstraZeneca